These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9488871)

  • 1. Leishmania amazonensis promastigotes evade complement killing by interfering with the late steps of the cascade.
    Nunes AC; Almeida-Campos FR; Horta MF; Ramalho-Pinto FJ
    Parasitology; 1997 Dec; 115 ( Pt 6)():601-9. PubMed ID: 9488871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
    Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement resistance of Leishmania amazonensis promastigotes is independent of parasite proteases and lysis of sensitive forms is not due to natural antibodies in normal human serum.
    Nunes AC; Ramalho-Pinto FJ
    Braz J Med Biol Res; 1996 Dec; 29(12):1633-40. PubMed ID: 9222424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leishmania species: mechanisms of complement activation by five strains of promastigotes.
    Mosser DM; Burke SK; Coutavas EE; Wedgwood JF; Edelson PJ
    Exp Parasitol; 1986 Dec; 62(3):394-404. PubMed ID: 3780933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum resistance of metacyclic stage Leishmania major promastigotes is due to release of C5b-9.
    Puentes SM; Da Silva RP; Sacks DL; Hammer CH; Joiner KA
    J Immunol; 1990 Dec; 145(12):4311-6. PubMed ID: 2147941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum-resistant strains of Borrelia burgdorferi evade complement-mediated killing by expressing a CD59-like complement inhibitory molecule.
    Pausa M; Pellis V; Cinco M; Giulianini PG; Presani G; Perticarari S; Murgia R; Tedesco F
    J Immunol; 2003 Mar; 170(6):3214-22. PubMed ID: 12626580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth cycle-dependent generation of complement-resistant Leishmania promastigotes.
    Franke ED; McGreevy PB; Katz SP; Sacks DL
    J Immunol; 1985 Apr; 134(4):2713-8. PubMed ID: 3973390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the alternative complement pathway by Leishmania promastigotes: parasite lysis and attachment to macrophages.
    Mosser DM; Edelson PJ
    J Immunol; 1984 Mar; 132(3):1501-5. PubMed ID: 6363545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The macrophage-attachment glycoprotein gp63 is the predominant C3-acceptor site on Leishmania mexicana promastigotes.
    Russell DG
    Eur J Biochem; 1987 Apr; 164(1):213-21. PubMed ID: 3549304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lytic rabbit IgG for tissue culture trypomastigotes of Trypanosoma cruzi alters the extent and form of complement deposition.
    Rimoldi MT; Tartanian A; Joiner KA
    Exp Parasitol; 1989 Feb; 68(2):160-7. PubMed ID: 2647504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential surface deposition of complement proteins on logarithmic and stationary phase Leishmania chagasi promastigotes.
    Ramer-Tait AE; Lei SM; Bellaire BH; Beetham JK
    J Parasitol; 2012 Dec; 98(6):1109-16. PubMed ID: 22662870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.
    Rosenfeld SI; Jenkins DE; Leddy JP
    J Immunol; 1985 Jan; 134(1):506-11. PubMed ID: 3964820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evasion of alternative complement pathway by Trypanosoma cruzi results from inefficient binding of factor B.
    Joiner K; Sher A; Gaither T; Hammer C
    Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6593-7. PubMed ID: 2944112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage toxicity and complement sensitivity of virulent and avirulent strains of Legionella pneumophila.
    Caparon M; Johnson W
    Rev Infect Dis; 1988; 10 Suppl 2():S377-81. PubMed ID: 3187322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxoplasma gondii: mechanism of resistance to complement-mediated killing.
    Fuhrman SA; Joiner KA
    J Immunol; 1989 Feb; 142(3):940-7. PubMed ID: 2643665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leishmania amastigotes: resistance to complement-mediated lysis is not due to a failure to fix C3.
    Mosser DM; Wedgwood JF; Edelson PJ
    J Immunol; 1985 Jun; 134(6):4128-31. PubMed ID: 3886796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leishmania mexicana: induction of metacyclogenesis by cultivation of promastigotes at acidic pH.
    Bates PA; Tetley L
    Exp Parasitol; 1993 Jun; 76(4):412-23. PubMed ID: 8513879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement binding by two developmental stages of Leishmania major promastigotes varying in expression of a surface lipophosphoglycan.
    Puentes SM; Sacks DL; da Silva RP; Joiner KA
    J Exp Med; 1988 Mar; 167(3):887-902. PubMed ID: 3280727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amastigotes of Trypanosoma cruzi escape destruction by the terminal complement components.
    Iida K; Whitlow MB; Nussenzweig V
    J Exp Med; 1989 Mar; 169(3):881-91. PubMed ID: 2494292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.